GSK: ‘Armageddon’ Claims Overstated For Skinny-Label Generics

Originator Pushes Back Against Teva Petition For Federal Circuit ‘En Banc’ Rehearing

Armageddon Asteroid Hit Earth End Of World
GSK insists the decisions do not represent “doomsday” for skinny labels • Source: Alamy

More from Legal & IP

More from Generics Bulletin